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RESEARCH PAPER
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negro (Leptocarpha rivularis DC. – Asteraceae) and evaluation of its antioxidant
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ABSTRACT
UHPLC/ESI/MS identification of organic compounds is the first step in the majority of screening techniques
for the characterization of biologically active metabolites in natural sources. This paper describes a method
for the fast identification and characterisation of secondary metabolites in Leptocarpha rivularis DC. (Palo
negro) extracts by HPLC/UV (DAD)–Mass Spectrometry (HPLC/MS). The plant is used for the treatment of
several diseases since pre-hispanic Mapuche times. Thirty-seven compounds were detected in the aqueous
edible extract for the first time including 4 sesquiterpenes, 10 flavonoids, 9 oxylipins, 2 organic acids, and
11 phenolic acids. In addition, phenolic content antioxidant and cholinesterase inhibitory activities were
measured for the first time using the edible infusion. The total polyphenol content of the infusion was
230.76±2.5mmol GAE/kg dry weight, while the antioxidant activity was 176.51±28.84; 195.28±4.83; and
223.92±2.95mmol TE/kg dry weight, for the DPPH, ABTS, and FRAP assays, respectively. The cholinesterase
inhibitory activity was 7.38 ±0.03 and 5.74±0.06mmol GALAE/kg, for the inhibition of acetylcholinesterase
AChE and BChE, respectively, showing that this plant is a candidate for the isolation of compounds that
can be useful for the treatment of neurodegenerative diseases. Furthermore, this plant could serve also as
a raw material for the production of dietary supplements, due to its content of polyphenolic compounds.
ARTICLE HISTORY
Received 3 January 2018
Revised 12 April 2018
Accepted 13 April 2018
KEYWORDS
Electrospray; antioxidants;
metabolomics; Orbitrap;
Leptocarpha rivularis
Introduction
Leptocarpha rivularis DC. (Asteraceae), a native bush with the local
name Palo negro in Chile, and C€udu-mam€ell in Mapudungun lan-
guage: kud€u black; mam€ell wood, tree) is a medicinal South
American native plant, which grows in the Valdivian forest, with
exposure to large amounts of water and sun, generally growing in
marshes or in permanent watercourses. This evergreen bush
belongs to the family Asteraceae (Compositae) and to the genus
Leptocarpha, which has only this species. This bush has been
widely used in traditional Mapuche medicine for gastrointestinal
and stomach ailments since pre-Hispanic times, and now it is
largely sold in local markets and pharmacies for the prevention of
cancer (Figure 1). Previous partial phytochemical studies of this
plant showed the presence of sesquiterpenes1,2 and among them,
the main active compound is the heliangolide leptocarpin2,3,
which is an inhibitor of NF-kappa B and thus cytotoxic for cancer
cells3. Palo negro is also a source of lipophilic compounds present
in its essential oil, namely: alpha-thujone, beta-caryophyllene, and
caryophyllene oxide, which were quantified mostly in the leaves4,5
and reported responsible for some of the antioxidant properties of
the plant6. However, no chemical properties of the aqueous
extract (the infusion, the edible medicinal form) was reported so
far to the best of our knowledge.
In recent years, phenolic compounds gained great attention for
the design of new nutraceuticals and phyto-pharmaceuticals, due
to their important biological activities such as anti-inflammatory,
antioxidant, anticancer, or antibacterial7,8. Indeed, the finding of
herbs or medicinal plants with the presence of a high content of
phenolics can be convenient to produce medicines to counteract
oxidative stress conditions in the human body, and other diseases
related to chronic inflammation.
On the other hand, diseases of the central nervous system
(CNS) are responsible for 12% of worldwide deaths, and several
people suffering from these diseases such as chronic neurodege-
nerative conditions (i.e. Alzheimer's disease (AD) and Parkinson's
disease) are reported to have a poor quality of life9. So far, there
are 30 million people affected with neurodegenerative conditions
and these numbers will be rising by 204010. China, Western Pacific
countries, Eastern Europe, and the United States have the largest
number of people affected by these diseases11. Consequently, in
the last decade, there is a growing interest into new compounds’
discovery for the treatment or prevention of mentioned diseases,
CONTACT Olimpo Garcıa-Beltran jose.garcia@unibague.edu.co Facultad de Ciencias Naturales y Matematicas, Universidad de Ibague, Carrera 22 calle 67,
Ibague 730002, Colombia; Mario Simirgiotis mario.simirgiotis@uach.cl Instituto de Farmacia, Facultad de Ciencias, Universidad Austral de Chile, Campus Isla,
Teja 5090000, Valdivia, Chile
Supplemental data for this article can be accessed here.
 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
2018, VOL. 33, NO. 1, 936–944
https://doi.org/10.1080/14756366.2018.1466880
which could mimic neurotrophic factors, lower the oxidative stress
status within the nervous system cells, increment neurotransmit-
ters, or act as neuromodulators to accelerate neurogenesis12,13.
Among the treatment strategies for those degenerative diseases
are cholinesterase inhibitors such as galantamine14. Phenolic com-
pounds present in extracts from a vast number of edible fruits,
mushrooms, and herbs including Salvia officinalis, Melissa officina-
lis, Laurus nobilis, Mentha suaveolens, Lavandula angustifolia,
Lavandula pedunculata showed also anticholinesterase (AChE)
activity, and are considered rich sources of molecules useful for
the prevention and treatment of those neurodegenerative
diseases15–17.
In this work, we have performed antioxidant capacity and AChE
inhibitory activity of some extracts from Palo Negro and in order
to characterise chemically the extracts, we used modern state of
the art analytical equipment, such as ultra HPLC hyphenated with
diode array and high resolution quadrupole OrbitrapVR mass spec-
trometry (UHPLC-DAD-Q-OT-MS).
Among the state of the art OrbitrapVR instruments in the market,
the Q-Exactive Focus can detect and quantify small organic com-
pounds such as phenolics and others using a combination of diode
array detection with an orbital trap (OrbitrapVR ), a quadrupole (Q)
and a high-performance collision cell (HCD), allowing also high
mass diagnostic MS fragments18–22. This tool was very important
for our research in the last few years particularly, for the identifica-
tion of phenolic metabolites in Chilean plants23–26. In the present
article, the chemical fingerprinting of the medicinal plant’s infusion
L. rivularis (Figure 1) was performed for the first time based on
UHPLC-DAD coupled with high-resolution electrospray ionization
OrbitrapVR tandem mass spectrometry (UHPLC-DAD-Q-OT-MS). Since
no previous studies were reported on antioxidant and cholinester-
ase inhibitory activity of Palo negro polar extracts and its edible
infusions, those assays were performed to correlate the phenolic
profiles with these important bioactivities.
Materials and methods
Plant material
L. rivularis DC. aerial parts were collected in Valdivia, in November
2016 and were identified by the botanist Alicia Marticorena from
the University of Concepcion, Chile. Voucher specimens are kept
at the Natural Products Laboratory of the Universidad Austral de
Chile, under reference number: LR20161115.
Chemicals
UHPLC-MS Solvents, LC-MS formic acid and reagent chloroform
were marketed from Merck (Santiago, Chile). Ultrapure water was
obtained from a Millipore purification system (Milli-Q Merck
Millipore, Santiago, Chile). UHPLC standards, (citric acid, caffeic
acid, chlorogenic acid, gallic acid, isorhamnetin, diosmetin and ros-
marinic acid, all standards with a purity higher than 95% for HPLC)
were acquired either from Sigma Aldrich (Saint Louis, MO, USA),
ChromaDex (Santa Ana, CA, USA), or Extrasynthese (Genay,
France). Folin-Cioca^lteu phenol reagent (2 N), reagent grade
Na2CO3, AlCl3, HCl, FeCl3, NaNO2, NaOH, quercetin, trichloroacetic
acid, sodium acetate, Tris-HCl buffer, Gallic acid, 2,4,6-Tris(2-pyr-
idyl)-1,3,5-triazine (TPTZ), Trolox, nitroblue tetrazolium, xanthine
oxidase, Acetylcholinesterase (AChE Electric eel, Type-VI-S, EC
3.1.1.7), butylcholinesterase (BChE from horse serum, EC 3.1.1.8)
and DPPH (1,1-diphenyl-2-picrylhydrazyl radical) were acquired
from Sigma-Aldrich Chemical Co. (Santiago, Chile).
Sample preparation
Three grams (each extraction) of dried and milled aerial parts
(leaves and stems) were separately macerated with ethanol
(1 time, 250ml at 25 C), ethyl acetate (1 time, 250ml, at 25 C),
for one hour. An infusion was prepared using 3 g of dried milled
aerial parts adding deionized water (250ml) at 85 C, for 1 h. The
solvents were concentrated in vacuo at 45 C, and the infusion
was lyophilized (Labconco 2.5 l) to obtain 229, 243, and 343mg of
ethanol, ethyl acetate, and aqueous extracts, respectively.
UHPLC-DAD-MS instrument
The Dionex Thermo Scientific Ultimate 3000 UHPLC system
(Bremen, Germany), hyphenated with a Thermo Q Exactive focus
machine protocol was already reported22. For the analysis, each of
the extracts were re-dissolved (2mg per mL) in ethanol-distilled
Figure 1. L. rivularis as it is sold in the street markets in Valdivia, Chile.
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water (1:1 v/v) and 10 mL of filtered solution (PTFE filter) were
injected in the instrument, with all specifications set as previ-
ously reported22.
LC parameters
A binary gradient system with eluent (A) 0.1% formic acid in
water, eluent (B) 0.1% formic acid in acetonitrile and the follow-
ing gradient was used for the extracts: 10% B isocratic (0–1min),
10–40% B (1–30min), 40% B isocratic (30–33min), 40–10% B
(33–34min), and 10% B isocratic (34–37min). Liquid chromatog-
raphy was performed using an UHPLC C18 column (Acclaim,
150mm 4.6mm ID, 2.5 mm, Thermo Fisher Scientific, Bremen,
Germany) operated at 25 C. The detection wavelengths were
280, 254, 330, and 354 nm, (to detect mainly isoflavones-flava-
nones-flavanol, flavonols and phenolic acids) and PDA was
recorded from 200 to 800 nm for peak characterization. Mobile
phases were 1% aqueous formic acid solution (A) and acetonitrile
acidified with 1% formic acid (B). The following gradient was
used: 5% B isocratic (0–5min), 5–30% B (5–10min), 30% B iso-
cratic (10–15min), 30–70% B (15–20min), 70% B isocratic
(20–25min), 70–5% B (25–35min), and 15min for column equili-
bration before injections. The flow rate was 1.00mlmin1, and
the volume injected was 10ml. Standards and the resin extract
dissolved in solvent were kept at 10 C during storage in the
auto-sampler.
MS parameters
The HESI (heated electrospray ionization probe) parameters were
as follows: sheath gas flow rate, 75 units; auxiliary gas unit flow
rate, 20; capillary temperature, 400 C; auxiliary gas heater tem-
perature, 500 C; spray voltage, 2500 V (for ESI-); and S lens, RF
level 30. Full scan data in positive and negative were acquired at
a resolving power of 70,000 FWHM (full width half maximum) at
m/z 200. For the compounds of interest, a scan range of m/z
100–1000 was chosen; the automatic gain control (AGC) was set at
3 106 and the injection time was set to 200ms. The scan-rate
was set at 2 scans s1. External calibration was performed using a
calibration solution in positive and negative modes. For confirm-
ation purposes, a targeted MS-MS analysis was performed using
the mass inclusion list, with a 30 s time window, with the Orbitrap
spectrometer operating both in positive and negative modes at
17,500 FWHM (m/z 200). The AGC target was set to 2 105, with
the maximum injection time of 20ms. The precursor ions were fil-
tered by the quadrupole, which operated at an isolation window
of m/z 2. The fore vacuum, high vacuum and ultrahigh vacuum
were maintained at approximately 2 mbar, from 105 and below
1010 mbar, respectively. Collision energy (HCD cell) was operated
at 30 kV. Detection was based on calculated mass and on reten-
tion time of target compounds, as shown in Table 1. The mass tol-
erance window was set to 5 ppm for the two modes. The HESI II
and Orbitrap spectrometer parameters were set as stated
previously22.
Total phenolic and flavonoids content
The analysis of total phenolic content (TPC) was based on the
study performed by Simirgiotis et al.27 with slight modifications.
To 100 mL of extract, 940 mL of Milli-Q water and 480 mL of the
reagent Folin-Cioca^lteu (10%, Merck, Santiago, Chile) were added
to a test tube, mixed using a vortex. The prepared tube was
allowed to react for 5min, then 480 mL of 10% sodium carbonate
was added. The mixture was incubated at room temperature for
30min in the absence of light. Absorbance was then measured
at 765 nm using a UV-Vis. spectrophotometer (Spectroquant
Pharo 300 Merck, Santiago, Chile), using a Milli-Q water blank
with all other reagents without the sample. The absorbance val-
ues were replaced in the equation of a standard curve using gal-
lic acid (mmol L1). The total phenolic content was then
expressed as millimoles of gallic acid equivalents per kilogram of
dry sample weight (mmol GAE/kg extract). The aluminum chlor-
ide method was used for the determination of the total flavon-
oid content27. For this test, 1ml of the filtered infusion was
mixed into a 10ml volumetric bottle with 4ml of distilled water.
Then, 0.3ml of 5% NaNO2 was added to the bottle and hand
shook for 10 s. After 5min, 0.3ml 10% AlCl3 was added to the
sample mixture. At the sixth minute, 2ml of the 1M NaOH solu-
tion was added, and the volume filled to 10ml with water. The
absorbance was then measured at 510 nm, using UV-Visible spec-
trophotometer, after diluting the sample ten times (1:10 v/v sam-
ple mixture:water). Flavonoid content (TFC) was calculated using
a quercetin standard calibration curve (concentrations ranging
from 16.0 to 800.0 mg/mL, R2¼ 0.995). Results were expressed as
micromoles quercetin equivalents per kilogram of dry weight
(mmol QE/kg dry weight).
Antioxidant assays
DPPH cation radical test
The capturing capacity of the DPPH radical was evaluated by the
decolorization method developed by Brand-Williams et al.28, and
modified by Kim et al.29. Briefly, to 400ml of extract, (at 2mg/mL),
2ml of a 100 mM methanolic DPPH solution (Absorbance:
1.10 ± 0.02, at 517 nm) were added. The mixture was homogenised
using a vortex, and kept at room temperature for 20min in the
absence of light. The percentage of discoloration of the DPPH
moiety was calculated by reading the absorbance at 517 nm, and
the values obtained converted to percent inhibition of the DPPH
moiety using the following:
Percentage Inhibition ¼ 1 S:A:
B:A:
 
 100
where S.A. is sample absorbance and B.A. is blank absorbance.
The values were replaced in the Trolox standard curve equation
(mmol L1). The results were expressed as Trolox equivalent anti-
oxidant capacity (TEAC), in millimoles Trolox Equivalents per kilo-
gram of dry weight (mmol TE/kg dry weight)
Bleaching test with the cationic radical ABTS þ
The capturing capacity of the ABTSþ radical was evaluated by the
decolorisation method developed by Re et al. 1999 and modified
by Kuskoski et al. 200430. The radical ABTSþ is generated chem-
ically by the oxidation of ABTS with potassium persulfate after
16 h of incubation at room temperature in the dark. Briefly, to 2ml
of the ABTSþ solution (previously adjusted with 80% methanol in
ultrapure water, in order to obtain an absorbance of 0.70 ± 0.02 at
734 nm), 200 mL of the extract was added (prepared at 2mg/mL),
mixed using a vortex and allowed to react in the dark at room
temperature. The absorbance was then measured at 765 nm after
6min of incubation, and the values obtained converted to %
inhibition of the ABTSþ radical and substituted in the Trolox
standard curve equation (mmol L1). The results were expressed
as millimoles of Trolox equivalents per kilogram of dry weight
(mmol TE/kg dry weight).
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Ferric reduction antioxidant power test (FRAP)
For the FRAP test, the methodology proposed by Benzie and
Strain31, was used with some slight modifications. Briefly, to
200 mL of extract (2mg/mL), 2ml of the FRAP solution was added
and mixed using a vortex, allowing to react in the dark at room
temperature for 5min. The absorbance measurement of the col-
ored Fe-TPTZ complex was performed at 595 nm. Absorbance val-
ues were replaced in the Trolox standard curve equation
(mmol L1). The results were expressed as Trolox equivalents
(TE), in millimoles Trolox per kilogram of dry weight (mmol TE/kg
dry weight).
Superoxide anion scavenging assay
The xanthine oxidase enzyme yields superoxide anion radical (O2
2)
in vivo by oxidation of reduced products from intracellular ATP
metabolism. Xanthine oxidase has been reported to increase its
activity during oxidative stress and produce uric acid and super-
oxide anion radical. This radical reduces the blue nitro tetrazolium
dye (NBT), to mono- and di-formazan generated in the biological
system consisting of the enzyme xanthine oxidase (XOD) and
hypoxanthine at pH 7.4 forming a blue chromophore, which
absorbs at 520 nm. Superoxide anion scavengers reduce the speed
of generation of the chromophore. The assay involved the add-
ition of 20 ml of sample solution (extract at 100mg/mL) and 160 ml
of a reaction mixture containing 50mM potassium phosphate buf-
fer (pH 7.4), 0.2mM NBT, 0.6mM hypoxanthine, and 1mM EDTA.
The reaction started by the addition of 20ml of XOD (200mU/mL)
and incubation for 8min at 37 C. Allopurinol was used as a posi-
tive control. Extracts dissolved in water (containing 5% DMSO for
solubility) were used as sample solutions. The Superoxide anion
trapping activities (SAA) of the extracts were measured spectro-
photometrically as previously described32.
Cholinesterase (ChE) inhibition
Cholinesterase inhibitory activity was performed using Ellman’s
method, as stated previously33,34. The enzyme cholinesterase
hydrolyses the substrate acetylthiocholine and results in the prod-
uct thiocholine, which reacts with Ellman’s reagent (DTNB)
to produce 2-nitrobenzoate-5-mecraptothiocholine and 5-thio-2-
nitrobenzoate, which can be detected at 405 nm. Briefly, extracts
obtained were evaporated under reduced pressure and further
kept in a vacuum desiccator to fully remove traces of solvents.
DTNB was dissolved in the buffer Tris-HCl buffer at pH 8.0 contain-
ing 0.1M NaCl and 0.02M MgCl2. Then, a filtered (PTFE) sample
solution in deionised water (50mL, 2mg/mL) was mixed with
125 mL of 5-dithio-bis(2-nitrobenzoic) acid (DTNB), acetylcholin-
esterase (AChE), or butyrylcholinesterase (BChE) solution (25 mL)
dissolved in Tris-HCl buffer at pH 8.0placed in a 96-well microplate
and incubated for 15min at 25 C. The reaction was initiated with
the addition of acetyl-thiocholine iodide (ATCI) or butyryl-thiocho-
line chloride (BTCl) (25 mL). In addition, a blank was prepared by
adding the solution sample to all reagents without the enzyme(s)
(AChE or BChE) solutions. The sample and blank absorbance were
then recorded at 405 nm after 10min of incubation at 25 C. The
absorbance of the blank was subtracted from the absorbance of
the sample and the cholinesterase inhibitory capacity was
expressed as galantamine equivalents (calibration range (5–70 mg/
ml) per g extract.
Statistical analysis
The statistical analysis (ANOVA, five times for each determination)
set using the originPro 9.0 software package (Originlab
Corporation, Northampton, MA, USA).
High resolution mass-mass metabolite identification in
L. Rivularis
Electrospray Orbitrap became a versatile and very rapid tool for
the characterisation of phenolics in medicinal plants. This state of
the art technique was used to determine the metabolomic profiles
of L. rivularis and to set up chemical fingerprints that could be
useful for chemotaxonomy and identification of the plant material,
since other species are known by that local name in
Latin countries.
Figure 2 shows the total ion current chromatograms (TIC) of
L. rivularis extracts as: (a) ethanolic extract, (b) aqueous infusion,
(c) ethyl acetate extract and Figure S1 shows the full HR-MS spec-
tra and structures of some representative compounds. Conversely
and as expected, the ethyl acetate extract showed a poorer chem-
ical profile for these bioactive compounds. We have explained
below the rapid metabolome analysis of these three extracts
(ethanolic extract, ethyl acetate extract and infusion) prepared
from this species.
Aliphatic organic acids
Two compounds (Figure 2) were identified as simple aliphatic
organic acids, the first one was peak 1 showing a pseudomolecu-
lar ion at m/z 195.04993, which was identified as gluconic acid
(C6H11O7
)35, and the second one was citric acid (C6H7O7
,
peak 2)36.
Sesquiterpenes
Peak 25 with a [M–H] ion at m/z 361.16577 was characterised as
leptocarpin (C15H19O3
)3 and peaks 28 and 29, with [M–H] ions at
m/z 247.13390 and 247.13374 matching the formula: C15H19O3

were assigned to dehydrated derivatives of leptocarpin (Figure
S1g). Furthermore, peak 28 was one of the main compounds
(Figure 2) in the aqueous extract that could be responsible at least
in part, of the anticancer activity reported for this plant1,3. Peak 34
with a [M–H] ion at m/z 251.16518 (Figure S1k), was identified as
ilicic acid (C15H23O3
)37.
Phenolic acids
Peak 3 with a [M–H] ion at m/z 355.03070 was identified as
chebulic acid (C14H11O11
)38. Peak 4 showing a [M–H] ion at m/z
169.01639 was identified as gallic acid (C7H5O5
)39, while peak 5
was identified as protocatechuic acid 4-O-glucoside
(C13H15O9
)39,40, and peak 6, which showed a [M–H] ion at m/z
535.10823 was identified as 1,6-dicaffeoyl-glucose (C24H23O14
)41.
Furthermore, peaks 7–9 were identified as isomers of chlorogenic
acid (3, 4, and 5O-caffeoyl-quinic acids, respectively)
(C16H17O9)
42,43, all showing diagnostic [2 M–H] ions at around
m/z 707 and daughter ions at m/z 179.03465 (caffeic acid)26,39.
Peaks 14 and 15, showing pseudomolecular ions at m/z 515.11932
and 515.11957, respectively and yielding MS2 fragments at m/z
353 (caffeoyl quinic acid) were identified as di-caffeoyl quinic acid
isomers44 (C25H23O12
, Figure S1c). Finally, peak 17 was character-
ised as caffeic acid (C9H7O4
) and peak 33 with a [M–H] ion at m/
z 359.07614 (Figure S1j) was identified as the anti-inflammatory
compound rosmarinic acid (C18H15O8
)45.
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Flavonoids
Some compounds were tentatively characterised as flavonoid gly-
cosides, while some were identified as diosmetin and luteolin
derivatives. The UV spectra of quercetin, kaempferol, luteolin, and
diosmetin solutions in methanol are typical for flavones, and the
absorption maxima are observed in the range from 240 to 400 nm.
The UV maxima are attributed to bands related to absorption
involving an A-ring benzoyl system (usually 240–280 nm) and a B-
ring cinnamoyl system (300–380 nm). Accordingly, peak 10 with a
ion [M–H] at m/z 447.09329 was identified as kaempferol 3-O-glu-
cose (C21H19O11
)46, peak 11 with a anion [M–H] at m/z 577.15652
() and an apigenin MS2 ion at m/z 255.02986 was labeled as iso-
rhoifolin (apigenin 7-O-rutinose, C26H27O16
, Figure S1a)36, peak 12
with a [M–H] ion at m/z 463.08838 was identified as quercetin 3-
O-glucose (C21H19O12
)47 and peak 13 with a anion [M–H] at m/z
593.15010 (Figure S1b) as lonicerin (luteolin-7-O-neohesperidose,
C26H27O16
)36 and peak 16 as luteolin rhamnose (Figure S1d)48.
Peaks 18 and 20 were identified as the isomers: 30,50di-O-methyl-
myricetin49 and 7,30di-O-methylmyricetin (C17H13O8
), respectively.
Peak 26 with UV max characteristic of kaempferol (k max
266–419 nm) and with a ion [M–H] at m/z 337.10837 (Figure S1f)
was identified as 8-prenyl-kaempferol (C20H17O5
) and peak 24
(Figure S1e) was tentatively identified as the related compound 7-
O-methyl-8-prenyl luteolin (C21H19O6
), both prenylated flavones50.
Finally, peak 35 was identified as diosmetin (C16H11O6
, Figure
S1l)51 and peak 37 as isorhamnetin (C15H7O8
)36.
Oxylipins
Several compounds were identified as the dietary polyhydroxy-
lated unsaturated fatty acids known as oxylipins27,52, important
antioxidant fatty acids component of foods. Peak 19 and 21 with
ions [M–H] at m/z 327.21790 and 329.23358 were identified as
9,10,12-trihydroxy-octadecadienoic acid and 9,10,12-trihydroxyocta-
decaenoic acid53 respectively (C18H31O5
 and C18H31O5
). In the
same manner, peaks 22 and 23 (HESI-MS: 309.20604 and
307.19029 Daltons) were determined as 11-hydroxy-12-oxoocta-
deca-9,15-dienoic acid and 11-hydroxy-12-oxooctadeca-7,9,15-tri-
enoic acid, respectively. Peak 27 was assigned to 9-hydroxy-
octadecatrienoic acid (C18H29O3
) while peaks 30 and 31 as 9-
hydroxy-octadecatetraenoic acid (295.22677, C18H27O3
 Figure S1h)
and 9-hydroxy-octadecadienoic acid (C18H31O3
), respectively.
Finally, peak 32 with a ion [M–H] at m/z 325.23734 (Figure S1i)
was identified as 8-methoxy-13-hydroxy-9,11-octadecadienoic acid
(C19H33O4
) and peak 36 with a ion [M–H] at m/z 311.22169 as
dihydroxyoctadecadienoic acid (C18H31O4
)27,52.
Antioxidant capacities
In this study, several assays (DPPH, ABTS, FRAP, and SA) were per-
formed in order to quantify the antioxidant capacity of some Palo
negro extracts (Table 2). The antioxidant capacity measured by
DPPH method was 176.51 ± 28.84mmol TE/kg and in the FRAP
assay, the infusion exert a value of 223.92 ± 2.95mmol TE/kg.
Eleven antioxidants were identified as phenolic acids (peaks 3–9,
14, 15, 17, and 33) and 10 were flavonoids (peaks 10–13, 18, 20,
26, 24, 35, and 37) that could be responsible for the antioxidant
capacity presented. Furthermore, the nine oxylipins detected
(peaks 22, 23, 27, 30, 31, 32, and 36), as well as the two organic
acids (peaks 1 and 2) could contribute to the antioxidant activity.
In addition, the total phenolic content measured spectroscopically
Figure 2. UHPLC Chromatograms of L. rivularis extracts, (a) ethanolic extract, (b) aqueous infusion (c) ethyl acetate extract.
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(320.49 ± 3.58mmol GAE/kg) of the infusion (medicinal form used
traditionally) was higher to that already reported for the hydroal-
coholic extract (water:ethanol 80:20 v/v) of this plant (3.7 ± 0.02mg
GAE/g, or 21.76mmol GAE/kg)4. The difference could be explained
considering the extraction method used or stage of the plant col-
lected. The TPC and TFC values were also higher than those
reported for the bioactive-containing compounds plants Lathyrus
cicera and Lathyrus digitatus56.
Enzyme inhibitory properties
Acetylcholinesterase enzyme (AChE) plays a major role in the activ-
ity of the central and peripheral nervous systems, because it cataly-
ses the hydrolysis and inactivation of the acetylcholine
neurotransmitter, yielding choline and acetate. Cholinesterase
inhibitors improve the cholinergic function of Alzheimer’s disease
(AD), preserving the levels of acetylcholine, and, therefore have
become the standard approach in the symptomatic treatment of
AD. Those compounds, such as donepezil, galantamine, and riva-
stigmine, delay the degradation of the acetylcholine released into
the synaptic clefts and, thus reinforce cholinergic neurotransmis-
sion. In this context, enzyme inhibitory assays have become, in the
recent years, very useful tools to assess the potential health bene-
fits of herbal medicines, fruits, and related biological materials, for
the development of functional foods or dietary supplements56,57.
Moreover, most usual assays involve key enzymes relevant in
chronic neurodegenerative conditions such as AD (cholinester-
ases)58. In the present study, the effects of the investigated extracts
on selected cholinesterases were assessed by microtiter assays, the
results being depicted in Table 2. The aqueous infusion showed
better cholinesterase activities, (2.12 ± 0.03 and 1.65± 0.06 GALAE
per gram extract). The values are thrice higher than those reported
for leaves of the known medicinal plant Lycium barbarum (Goji)
(1.02± 0.17mg GALAE/g dry weight). However, chlorogenic acid,
one of the constituent of this plant, has been reported as a potent
enzyme inhibitory constituent of Goji leaves34 and blueberries42.
Another Asteraceae species (Xeranthemum annuum L.) showed also
BCHe inhibitory activity (the chloroform, ethanol and ethyl acetate
extracts of the aerial parts showed more than 90% inhibition,
superior even than galantamine, which showed 90% inhibition)59.
Other Asteraceae species, such as wild artichoke (Cynara cornigera),
which containt sesquiterpene lactones, showed also high-inhibitory
activity60. Calendula extracts (n-hexane, dichloromethane, acetone,
ethyl acetate, methanol, and water) of the leaf and flowers of
Calendula arvensis L. and C. officinalis L. were also inhibitors of
acetylcholinesterase (AChE) and butyrylcholinesterase (BChE)61.
Conclusions
The infusion of the endemic plant L. rivularis, which is used in the
Chilean traditional system of medicine for gastrointestinal ailments
and prevention of cancer, showed antioxidant and cholinesterase
inhibitory activities. Several phenolic and other interesting com-
pounds were identified in the infusion of this important Mapuche
species for the first time. Among the compounds detected, 4 were
sesquiterpenes (peaks 34, 25, 28, and 29), 10 were flavonoids
(peaks 10–13, 18, 20, 26, 24, 35, and 37), 9 were oxylipins (peaks
22, 23, 27, 30, 31, 32, and 36), 2 were organic acids (peaks 1 and
2), and 11 were phenolic acids (peaks 3–9, 14, 15, 17, and 33). The
results confirm that this plant is a rich source of phenolic com-
pounds that could be responsible for the bioactivity reported and
the medicinal use. The infusion and its active components could
emerge as natural antioxidants, or serve as raw materials for the
isolation of effective AChE inhibitors, thus being a promising
potential complementary source against Alzheimer's disease and
related diseases.
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